Related Experiment Videos
Severe thrombocytopenia due to apalcillin
1Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago.
Urologia Internationalis
|January 1, 1987
Summary
Penicillin use can impair platelet function, but low platelet counts are rare. This report details the first known case of apalcillin-induced thrombocytopenia, a seldom-seen adverse effect of penicillin antibiotics.
Area of Science:
- Pharmacology
- Hematology
- Clinical Medicine
Background:
- Penicillins are widely used antibiotics with a known association with impaired platelet aggregation.
- Thrombocytopenia, a significant decrease in platelet count, is an infrequently reported adverse effect of penicillin therapy.
Observation:
- A case of severe thrombocytopenia was observed in a patient following administration of apalcillin, a penicillin derivative.
- This represents the first documented instance of apalcillin specifically causing thrombocytopenia.
Findings:
- The patient developed significant thrombocytopenia attributed to apalcillin exposure.
- A review of existing literature confirms that penicillin-induced thrombocytopenia is a rare but recognized phenomenon.
Implications:
- This case highlights the importance of considering apalcillin as a potential cause of thrombocytopenia in patients receiving this antibiotic.
- Clinicians should be vigilant for this uncommon adverse effect, even with other penicillins.
- Further investigation into the mechanisms of penicillin-induced thrombocytopenia is warranted.